CoChat

Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)

Open access
Keeney, Jeriel T. R., Ren, Xiaojia, Warrier, Govind, Noel, Teresa, Powell, David K., Brelsfoard, Jennifer M., Sultana, Rukhsana, Saatman, Kathryn E., St. Clair, Daret K., Butterfield, D. Allan · 2018 · Oncotarget
Cited by 157

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

// Jeriel T. R. Keeney 1, * , Xiaojia Ren 1, * , Govind Warrier 1 , Teresa Noel 2 , David K. Powell 3 , Jennifer M. Brelsfoard 4 , Rukhsana Sultana 1 , Kathryn E. Saatman 4 , Daret K. St. Clair 2, 5, 6 and D. Allan Butterfield 1, 6, 7 1 Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA 2 Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA 3 Magnetic Resonance Imaging and Spectroscopy Center, University of Kentucky Medical Center, Lexington, KY 40536, USA 4 Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA 5 Department of Radiation Medicine, University of Kentucky, Lexington, KY 40502, USA 6 Markey Cancer Center, University of Kentucky, Lexington, KY 40502, USA 7 Sanders Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA * Co-first authors Correspondence to: D. Allan Butterfield, email: dabcns@uky.edu Keywords: chemotherapy induced cognitive impairment; oxidative stress; choline; cognitive dysfunction Received: December 19, 2017 Accepted: June 13, 2018 Published: July 13, 2018 ABSTRACT Chemotherapy-induced cognitive impairment (CICI) is now widely recognized as a real and too common complication of cancer chemotherapy experienced by an ever-growing number of cancer survivors. Previously, we reported that doxorubicin (Dox), a prototypical reactive oxygen species (ROS)-producing anti-cancer drug, results in oxidation of plasma proteins, including apolipoprotein A-I (ApoA-I) leading to tumor necrosis factor-alpha (TNF-α)-mediated oxidative stress in plasma and brain. We also reported that co-administration of the antioxidant drug, 2-mercaptoethane sulfonate sodium (MESNA), prevents Dox-induced protein oxidation and subsequent TNF-α elevation in plasma. In this study, we measured oxidative stress in both brain and plasma of Dox-treated mice both with and without MESNA. MESNA ameliorated Dox-induced oxidative protein damage in plasma, confirming our prior studies, and in a new finding led to decreased oxidative stress in brain. This study also provides further functional and biochemical evidence of the mechanisms of CICI. Using novel object recognition (NOR), we demonstrated the Dox administration resulted in memory deficits, an effect that was rescued by MESNA. Using hydrogen magnetic resonance imaging spectroscopy (H 1 -MRS) techniques, we demonstrated that Dox administration led to a dramatic decrease in choline-containing compounds assessed by (Cho)/creatine ratios in the hippocampus in mice. To better elucidate a potential mechanism for this MRS observation, we tested the activities of the phospholipase enzymes known to act on phosphatidylcholine (PtdCho), a key component of phospholipid membranes and a source of choline for the neurotransmitter, acetylcholine (ACh). The activities of both phosphatidylcholine-specific phospholipase C (PC-PLC) and phospholipase D were severely diminished following Dox administration. The activity of PC-PLC was preserved when MESNA was co-administered with Dox; however, PLD activity was not protected. This study is the first to demonstrate the protective effects of MESNA on Dox-related protein oxidation, cognitive decline, phosphocholine (PCho) levels, and PC-PLC activity in brain and suggests novel potential therapeutic targets and strategies to mitigate CICI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.25718

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 157

Metadata

Authors
Keeney, J. T. R., Ren, X., Warrier, G., Noel, T., Powell, D. K., Brelsfoard, J. M., Sultana, R., Saatman, K. E., St. Clair, D. K., & Butterfield, D. A.
Venue
Oncotarget
Published
2018-07-13
Volume
9
Issue
54
Pages
30324-30339
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2883872827
Cited by
157
References
19
FWCI
10.48
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.